DUALITYBIO-B (09606.HK) Shareholders - Institutional Holders, Major Shareholders & Insiders | Longbridge

© 2026 Longbridge｜Terms of Service Privacy Policy

Shareholder Type

Institutions46.91%
VC/PE firms21.62%
Individuals & Insiders12.72%
Public and others9.61%
Others9.15%

Major Shareholders

Major Shareholders Latest
Shareholder
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	14.59%	13.26M	0.01%	+105.00K	05/26/2026
Zhongyuan ZhuCEO & Chairman	7.26%	6.59M	0.01%	+34.20K	06/26/2026
Xiamen Yinglian Health Industry Investment Management Co., Ltd.	7.03%	6.39M	0.05%	+0	12/31/2025
King Star Med Management Limited	4.95%	4.50M	0.03%	+0	03/12/2026
Wuxi Biologics Healthcare Venture	4.59%	4.17M	0.03%	+0	04/15/2025
Fei Chen	4.13%	3.76M	0.03%	+0	04/15/2025
CICC Private Equity Investment Management Co., Ltd.	3.68%	3.35M	0.03%	+0	04/15/2025
Sino Biopharmaceutical Limited	3.67%	3.33M	0.03%	+0	04/15/2025
Wellington Management Group LLP	3.33%	3.03M	<0.01%	+14.92K	12/31/2025
Suzhou Oriza Holdings Co., Ltd.	2.76%	2.51M	0.02%	+0	04/15/2025
Vanguard Capital Management, LLC	2.64%	2.40M	<0.01%	+1.60K	07/31/2026
Green Pine Capital Partners Co., Ltd.	2.07%	1.88M	0.01%	+0	04/15/2025
China Universal Asset Management Company Ltd.	1.94%	1.76M	0.01%	+0	12/31/2025
Suzhou Huagai Yizhen Equity Investment Partnership (Limited Partnership)	1.89%	1.72M	0.01%	+0	04/15/2025
Sw Biotech I Lpf	1.84%	1.67M	0.01%	+0	04/15/2025
Xiamen Qisheng Venture Capital Co., Ltd.	1.66%	1.51M	0.01%	+0	04/15/2025
Hangzhou Tailong Venture Capital Partnership Enterprise (L.P.)	1.66%	1.51M	0.01%	+0	04/15/2025
Nga Chun Chau	1.33%	1.21M	<0.01%	+0	04/15/2025
Capital Research and Management Company	1.16%	1.05M	0.04%	+43.90K	06/30/2026
Tasly Pharmaceutical Group Co., Ltd	1.11%	1.00M	<0.01%	+0	04/15/2025